TY - JOUR
T1 - Biomarkers for the Discrimination of Acute Kawasaki Disease From Infections in Childhood
AU - Zandstra, Judith
AU - van de Geer, Annemarie
AU - Tanck, Michael W.T.
AU - van Stijn-Bringas Dimitriades, Diana
AU - Aarts, Cathelijn E.M.
AU - Dietz, Sanne M.
AU - van Bruggen, Robin
AU - Schweintzger, Nina A.
AU - Zenz, Werner
AU - Emonts, Marieke
AU - Zavadska, Dace
AU - Pokorn, Marko
AU - Usuf, Effua
AU - Moll, Henriette A.
AU - Schlapbach, Luregn J.
AU - Carrol, Enitan D.
AU - Paulus, Stephane
AU - Tsolia, Maria
AU - Fink, Colin
AU - Yeung, Shunmay
AU - Shimizu, Chisato
AU - Tremoulet, Adriana
AU - Galassini, Rachel
AU - Wright, Victoria J.
AU - Martinón-Torres, Federico
AU - Herberg, Jethro
AU - Burns, Jane
AU - Levin, Michael
AU - Kuijpers, Taco W.
AU - EUCLIDS Consortium, PERFORM Consortium and UK Kawasaki Disease Genetics Study Network
N1 - Funding Information:
We would like to thank all the patients and their relatives as well as the treatment teams for their participation in this study. We also thank Dr. Mischa Keizer for his help in developing the MRP8/14 ELISA. We would like to thank the EUCLIDS Consortium, PERFORM Consortium, and the Genetic Determinants of Kawasaki Disease Study group (UK). Funding. This work was partially supported by the European Seventh Framework Program for Research and Technological Development (FP7) under EUCLIDS grant agreement no. 279185; from the European Union's Horizon 2020 research and innovation program under grant agreement no. 668303; by STINAFO and anonymous donor; and by Sanquin Blood Supply Product and Process Development Cellular Products Fund (PPOC 1957).
Publisher Copyright:
© Copyright © 2020 Zandstra, van de Geer, Tanck, van Stijn-Bringas Dimitriades, Aarts, Dietz, van Bruggen, Schweintzger, Zenz, Emonts, Zavadska, Pokorn, Usuf, Moll, Schlapbach, Carrol, Paulus, Tsolia, Fink, Yeung, Shimizu, Tremoulet, Galassini, Wright, Martinón-Torres, Herberg, Burns, Levin, Kuijpers, EUCLIDS Consortium, PERFORM Consortium and UK Kawasaki Disease Genetics Study Network.
Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.
PY - 2020/7/22
Y1 - 2020/7/22
N2 - Background: Kawasaki disease (KD) is a vasculitis of early childhood mimicking several infectious diseases. Differentiation between KD and infectious diseases is essential as KD's most important complication—the development of coronary artery aneurysms (CAA)—can be largely avoided by timely treatment with intravenous immunoglobulins (IVIG). Currently, KD diagnosis is only based on clinical criteria. The aim of this study was to evaluate whether routine C-reactive protein (CRP) and additional inflammatory parameters myeloid-related protein 8/14 (MRP8/14 or S100A8/9) and human neutrophil-derived elastase (HNE) could distinguish KD from infectious diseases. Methods and Results: The cross-sectional study included KD patients and children with proven infections as well as febrile controls. Patients were recruited between July 2006 and December 2018 in Europe and USA. MRP8/14, CRP, and HNE were assessed for their discriminatory ability by multiple logistic regression analysis with backward selection and receiver operator characteristic (ROC) curves. In the discovery cohort, the combination of MRP8/14+CRP discriminated KD patients (n = 48) from patients with infection (n = 105), with area under the ROC curve (AUC) of 0.88. The HNE values did not improve discrimination. The first validation cohort confirmed the predictive value of MRP8/14+CRP to discriminate acute KD patients (n = 26) from those with infections (n = 150), with an AUC of 0.78. The second validation cohort of acute KD patients (n = 25) and febrile controls (n = 50) showed an AUC of 0.72, which improved to 0.84 when HNE was included. Conclusion: When used in combination, the plasma markers MRP8/14, CRP, and HNE may assist in the discrimination of KD from both proven and suspected infection.
AB - Background: Kawasaki disease (KD) is a vasculitis of early childhood mimicking several infectious diseases. Differentiation between KD and infectious diseases is essential as KD's most important complication—the development of coronary artery aneurysms (CAA)—can be largely avoided by timely treatment with intravenous immunoglobulins (IVIG). Currently, KD diagnosis is only based on clinical criteria. The aim of this study was to evaluate whether routine C-reactive protein (CRP) and additional inflammatory parameters myeloid-related protein 8/14 (MRP8/14 or S100A8/9) and human neutrophil-derived elastase (HNE) could distinguish KD from infectious diseases. Methods and Results: The cross-sectional study included KD patients and children with proven infections as well as febrile controls. Patients were recruited between July 2006 and December 2018 in Europe and USA. MRP8/14, CRP, and HNE were assessed for their discriminatory ability by multiple logistic regression analysis with backward selection and receiver operator characteristic (ROC) curves. In the discovery cohort, the combination of MRP8/14+CRP discriminated KD patients (n = 48) from patients with infection (n = 105), with area under the ROC curve (AUC) of 0.88. The HNE values did not improve discrimination. The first validation cohort confirmed the predictive value of MRP8/14+CRP to discriminate acute KD patients (n = 26) from those with infections (n = 150), with an AUC of 0.78. The second validation cohort of acute KD patients (n = 25) and febrile controls (n = 50) showed an AUC of 0.72, which improved to 0.84 when HNE was included. Conclusion: When used in combination, the plasma markers MRP8/14, CRP, and HNE may assist in the discrimination of KD from both proven and suspected infection.
KW - bacterial infection
KW - biomarker
KW - coronary aneurysm
KW - infectious disease
KW - kawasaki disease
KW - vasculitis
KW - viral infection
UR - http://www.scopus.com/inward/record.url?scp=85089086987&partnerID=8YFLogxK
U2 - 10.3389/fped.2020.00355
DO - 10.3389/fped.2020.00355
M3 - Article
C2 - 32775314
AN - SCOPUS:85089086987
VL - 8
JO - Frontiers in Pediatrics
JF - Frontiers in Pediatrics
M1 - 355
ER -